Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Sodium arsenite represses the expression of myogenin in C2C12 mouse myoblast cells through histone modifications and altered expression of Ezh2, Glp, and Igf-1.

Hong GM, Bain LJ.

Toxicol Appl Pharmacol. 2012 May 1;260(3):250-9. doi: 10.1016/j.taap.2012.03.002. Epub 2012 Mar 9.

2.

Sodium arsenite delays the differentiation of C2C12 mouse myoblast cells and alters methylation patterns on the transcription factor myogenin.

Steffens AA, Hong GM, Bain LJ.

Toxicol Appl Pharmacol. 2011 Jan 15;250(2):154-61. doi: 10.1016/j.taap.2010.10.006. Epub 2010 Oct 18.

3.
4.

MicroRNA-26a targets the histone methyltransferase Enhancer of Zeste homolog 2 during myogenesis.

Wong CF, Tellam RL.

J Biol Chem. 2008 Apr 11;283(15):9836-43. doi: 10.1074/jbc.M709614200. Epub 2008 Feb 15.

5.
8.

Arsenite alters global histone H3 methylation.

Zhou X, Sun H, Ellen TP, Chen H, Costa M.

Carcinogenesis. 2008 Sep;29(9):1831-6. doi: 10.1093/carcin/bgn063. Epub 2008 Mar 4.

9.

Histone H3 modifications associated with differentiation and long-term culture of mesenchymal adipose stem cells.

Noer A, Lindeman LC, Collas P.

Stem Cells Dev. 2009 Jun;18(5):725-36. doi: 10.1089/scd.2008.0189.

PMID:
18771397
10.

The histone H3 lysine 9 methyltransferases G9a and GLP regulate polycomb repressive complex 2-mediated gene silencing.

Mozzetta C, Pontis J, Fritsch L, Robin P, Portoso M, Proux C, Margueron R, Ait-Si-Ali S.

Mol Cell. 2014 Jan 23;53(2):277-89. doi: 10.1016/j.molcel.2013.12.005. Epub 2014 Jan 2.

11.

Epigenetic regulation of cell adhesion and communication by enhancer of zeste homolog 2 in human endothelial cells.

Dreger H, Ludwig A, Weller A, Stangl V, Baumann G, Meiners S, Stangl K.

Hypertension. 2012 Nov;60(5):1176-83. doi: 10.1161/HYPERTENSIONAHA.112.191098. Epub 2012 Sep 10.

12.

Stress-induced C/EBP homology protein (CHOP) represses MyoD transcription to delay myoblast differentiation.

Alter J, Bengal E.

PLoS One. 2011;6(12):e29498. doi: 10.1371/journal.pone.0029498. Epub 2011 Dec 29.

13.

EZH2 suppresses hepatocellular differentiation of mouse bone marrow mesenchymal stem cells.

Lu T, Sun H, Lv J, Yang MF, Zhang F, Qian Y, Dong XJ.

Genet Mol Res. 2014 Mar 31;13(1):2231-9. doi: 10.4238/2014.March.31.3.

14.

Down-regulation of the histone methyltransferase EZH2 contributes to the epigenetic programming of decidualizing human endometrial stromal cells.

Grimaldi G, Christian M, Steel JH, Henriet P, Poutanen M, Brosens JJ.

Mol Endocrinol. 2011 Nov;25(11):1892-903. doi: 10.1210/me.2011-1139. Epub 2011 Sep 8.

16.

Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells.

Juan AH, Kumar RM, Marx JG, Young RA, Sartorelli V.

Mol Cell. 2009 Oct 9;36(1):61-74. doi: 10.1016/j.molcel.2009.08.008.

17.
18.

Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells.

Fiskus W, Pranpat M, Balasis M, Herger B, Rao R, Chinnaiyan A, Atadja P, Bhalla K.

Mol Cancer Ther. 2006 Dec;5(12):3096-104.

19.

Epigenetic histone modification of Epstein-Barr virus BZLF1 promoter during latency and reactivation in Raji cells.

Murata T, Kondo Y, Sugimoto A, Kawashima D, Saito S, Isomura H, Kanda T, Tsurumi T.

J Virol. 2012 May;86(9):4752-61. doi: 10.1128/JVI.06768-11. Epub 2012 Feb 22.

20.

Expression of the myodystrophic R453W mutation of lamin A in C2C12 myoblasts causes promoter-specific and global epigenetic defects.

HÃ¥kelien AM, Delbarre E, Gaustad KG, Buendia B, Collas P.

Exp Cell Res. 2008 May 1;314(8):1869-80. doi: 10.1016/j.yexcr.2008.02.018. Epub 2008 Mar 7.

PMID:
18396274

Supplemental Content

Support Center